The MRC Clinical Trials Unit (MRC CTU) at UCL is at the forefront of resolving internationally important questions in infectious diseases and cancer, and delivering swifter and more effective translation of scientific research into patient benefits.
ICON8 trial shows having chemotherapy every week is no better than having it every three weeks for ovarian cancer
ICON8 was a large international trial looking at whether having smaller doses of chemotherapy more often could help women with epithelial ovarian, fallopian tube, or primary peritoneal cancer. These women are usually tre…
Join our RADICALS and ARTISTIC Twitter Q&A #ProstateRadiotherapy
On Thursday 28 November 2019, we'll be running a Twitter Q&A session about the RADICALS trial and the ARTISTIC meta-analysis - with the hashtag #ProstateRadiotherapy.
The 50th Union World Conference on Lung Health
MRC Clinical Trials Unit at UCL will be presenting results from the STREAM tuberculosis trial.
STAMPEDE provides further insight into treating prostate cancer
Further results from the STAMPEDE trial have been presented at European Society for Medical Oncology Congress 2019 over the last few days
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Major international clinical trials answering questions of global public health significance
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes
There's a #vacancy at the Centre of Behavioural Medicine, working with us on the RID-TB trial. Research Assistant (Health Psychology/ Public Health) Employer: UCL, School of Pharmacy Salary: £31,479 to £33,194 Closing date: 24.02.2020 📝Apply here📝: https://t.co/eCbAqV35mq